ERBB2 and breast carcinoma: In agreement with this hypothesis, our current findings reveal that among EVOO phenolics tested, oleuropein aglycone is a potent phytochemical that significantly decreases breast cancer cell proliferation and survival by sharing OA's ability to suppress both the expression and the activity of HER2 oncogene in cultured breast cancer cells.